About 400 reports

  • Diagnosis of lymphoma
  • Tests for lymphoma
  • Lymphoma
  • Forecast
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited
  • Lymphoma Treatment Drugs Sales Volume
  • Lymphoma Treatment Drugs Sales Volume
  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Shandong Luoxin Pharmacy Stock Co., Ltd.
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Key Features of the Report: - Non-Hodgkins Lymphoma Patient Flow - Non-Hodgkins Lymphoma Prevalence - Non-Hodgkins Lymphoma Diagnosed Patients - Non-Hodgkins Lymphoma Treated Patients

  • Lymphoma
  • Europe
  • France
  • World
  • Forecast
  • III. LYMPHOMA
  • Lymphoma Treatment Drugs Sales Volume
  • Lymphoma
  • China
  • Beijing Wintic Pharma Co., Ltd
  • Ltd Jiangsu Hengrui Medicine Co.
  • Ltd Shenzhen Main Luck Pharmaceuticals Inc.
  • Marketed Drugs: Follicular Lymphoma
  • Pipeline: Follicular Lymphoma
  • Lymphoma
  • Europe
  • Japan
  • Biogen Idec Inc.
  • Roche Group
  • Epidemiology: Mantle Cell Lymphoma
  • TREATMENT: MANTLE CELL LYMPHOMA
  • Lymphoma
  • Europe
  • Celgene Corporation
  • Pfizer Inc.
  • Roche Group
  • Ann Arbor staging used in lymphoma
  • NON-HODGKIN'S LYMPHOMA IS SLIGHTLY MORE COMMON IN MALES
  • Lymphoma
  • Europe
  • Japan
  • Celgene Corporation
  • Roche Group
  • Lymphoma Treatment Drugs Exports
  • Other Lymphoma Treatment Drugs
  • Lymphoma
  • China
  • Demand
  • Trade
  • Pfizer Inc.

Hodgkin Lymphoma Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hodgkin Lymphoma pipeline products, Hodgkin Lymphoma epi

  • Lymphoma
  • France
  • Germany
  • Italy
  • Market Size

Non-Hodgkin Lymphoma Market Forecast ($), Japan, 2015 – 2020 The latest research from Fore Pharma, Global Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Non-Hodgkin Lymphoma pipeline products, Non-Hodgkin

  • Lymphoma
  • France
  • Germany
  • Italy
  • Market Size
  • 3.5.1 Follicular Lymphoma
  • 3.5.2 Marginal Zone Lymphoma
  • Lymphoma
  • Germany
  • Japan
  • Spain
  • Forecast

Key Features of the Report: - Non-Hodgkin' s Lymphoma: Disease Definition - Non-Hodgkin' s Lymphoma Patient Flow - Non-Hodgkin' s Lymphoma Prevalence - Non-Hodgkin' s Lymphoma Diagnosed Patients - Non-Hodgkin' s Lymphoma Treated Patien

  • Lymphoma
  • Europe
  • France
  • World
  • Forecast
  • 5.2 References
  • Introduction
  • Cancer
  • Lymphoma
  • Oncology
  • Therapy
  • United Kingdom

The 2018-2023 World Outlook for non-Hodgkin Lymphoma (NHL) Therapeutics ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Cancer
  • Lymphoma
  • Demand

Key Features of the Report: - Non-Hodgkins Lymphoma Patient Flow - Non-Hodgkins Lymphoma Prevalence - Non-Hodgkins Lymphoma Diagnosed Patients - Non-Hodgkins Lymphoma Treated Patients

  • Lymphoma
  • Europe
  • France
  • Germany
  • Forecast
  • Incidence of Burkitt's Lymphoma, (000s)
  • B-CELL LYMPHOMAS
  • Lymphoma
  • Asia
  • Europe
  • North America
  • Market Size

Large Cell Lymphoma - Market Overview ##.

  • Cancer
  • Lymphoma
  • Market Size
  • HODGKIN'S LYMPHOMA: KEY METRICS IN THE 7MM
  • TREATMENT GUIDELINES FOR HL
  • Lymphoma
  • Affimed Therapeutics AG
  • Incyte Corporation
  • Merck & Co., Inc.
  • Seattle Genetics, Inc.
  • Hodgkin's Lymphoma by stage, total (000s)
  • Incidence of Hodgkin's Lymphoma, males (000s)
  • Cancer
  • Lymphoma
  • Pathology
  • Europe
  • 4.3.2 Marginal Zone Lymphoma
  • 5.5.4 Mantle Cell Lymphoma
  • Lymphoma
  • AbbVie Inc.
  • GlobalData's company
  • Novartis AG
  • Roche Group

Hodgkin Lymphoma Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Hodgkin Lymphoma pipeline products, Hodgkin Lymphoma epidem

  • Lymphoma
  • Europe
  • France
  • Germany
  • Market Size

Non-Hodgkin Lymphoma Market Forecast ($), UK, 2015 – 2020 The latest research from Fore Pharma, Europe Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016, provides comprehensive insights into Non-Hodgkin Lymphoma pipeline products, Non-Hodgkin

  • Lymphoma
  • Europe
  • France
  • Germany
  • Market Size

Japan Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hodgkin Lymphoma Treatments ##) Hodgkin Lymphoma Pipeline ##) Japan Hodgkin Lymphoma Epidemiology ##) Marketed Drugs for Hodgk

  • Cancer
  • Lymphoma
  • Pathology
  • Japan
  • Market Size

Japan Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Non-Hodgkin Lymphoma Treatments ##) Non-Hodgkin Lymphoma Pipeline ##) Japan Non-Hodgkin Lymphoma Epidemiology ##) Marketed

  • Cancer
  • Lymphoma
  • Pathology
  • Japan
  • Market Size

Italy Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hodgkin Lymphoma Treatments ##) Hodgkin Lymphoma Pipeline ##) Italy Hodgkin Lymphoma Epidemiology ##) Marketed Drugs for Hodgk

  • Cancer
  • Lymphoma
  • Pathology
  • Italy
  • Market Size

France Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hodgkin Lymphoma Treatments ##) Hodgkin Lymphoma Pipeline ##) France Hodgkin Lymphoma Epidemiology ##) Marketed Drugs for Hod

  • Cancer
  • Lymphoma
  • Pathology
  • France
  • Market Size

UK Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hodgkin Lymphoma Treatments ##) Hodgkin Lymphoma Pipeline ##) UK Hodgkin Lymphoma Epidemiology ##) Marketed Drugs for Hodgkin

  • Cancer
  • Lymphoma
  • Pathology
  • United Kingdom
  • Market Size

Germany Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Hodgkin Lymphoma Treatments ##) Hodgkin Lymphoma Pipeline ##) Germany Hodgkin Lymphoma Epidemiology ##) Marketed Drugs for H

  • Cancer
  • Lymphoma
  • Pathology
  • Germany
  • Market Size

Italy Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Non-Hodgkin Lymphoma Treatments ##) Non-Hodgkin Lymphoma Pipeline ##) Italy Non-Hodgkin Lymphoma Epidemiology ##) Marketed

  • Cancer
  • Lymphoma
  • Pathology
  • Italy
  • Market Size

UK Non-Hodgkin Lymphoma Market and Competitive Landscape Highlights – 2016 ##) Disease Overview a) Etiology b) Pathophysiology c) Diagnosis ##) Non-Hodgkin Lymphoma Treatments ##) Non-Hodgkin Lymphoma Pipeline ##) UK Non-Hodgkin Lymphoma Epidemiology ##) Marketed Drugs

  • Cancer
  • Lymphoma
  • Pathology
  • United Kingdom
  • Market Size